EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical characteristics and outcomes of PCR-confirmed legionnaires’ disease identified by metagenomic sequencing in patients with hematological diseases

Chunhui Xu, Lining Zhang, Shulian Chen, Teng Liu, Guoqing Zhu, Ling Pan, Hui Wei, Gang An, Jun Shi, Yijun Song, Wenyu Yang, Erlie Jiang und 2 weitere

Frontiers in Cellular and Infection Microbiology · 20.11.2026 · 16

DOI: 10.3389/fcimb.2026.1826231 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 20.11.2026. Verfasst von Chunhui Xu und 13 weiteren Autor:innen. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Legionnaires’ disease (LD) is a severe form of pneumonia associated with high mortality in hematological patients, often due to delayed diagnosis. This study aimed to investigate clinical features, clinical severity, co-infections, molecular testing findings, and factors associated with 28-day mortality.

Methods

We retrospectively included hematological patients with pneumonia in whom Legionella pneumophila was detected by metagenomic next-generation sequencing (mNGS) and confirmed by PCR. Clinical, imaging, laboratory, treatment, and outcome data were collected.

Results

Among the 54 patients, 51.9% had severe LD and the overall 28-day mortality was 35.2%. In those with severe LD, the 28-day mortality was 67.9% (19/28). The main manifestations were fever (100%) and respiratory symptoms (cough 92.6%, expectoration 79.6%, dyspnea 64.8%). Imaging showed mass-like consolidation as the predominant pattern (61.1%), resembling invasive fungal pneumonia. Co-infections were identified in 61.1% of patients. In exploratory multivariable Cox analysis, elevated C-reactive protein (CRP) (HR = 1.106 per 10-mg/L increase, 95% CI, 1.035–1.186, P = 0.003) and higher blood-mNGS species-level stringently mapped read number (SMRN) (HR = 2.645 per tenfold increase, 95% CI, 1.523–5.008, P < 0.001) were associated with increased 28-day mortality. Before mNGS detection of L. pneumophila , only seven patients (13.0%) received empiric anti- Legionella therapy.

Conclusions

LD is a serious and potentially underrecognized infection in patients with hematological diseases. mNGS may facilitate the recognition of L. pneumophila infection when Legionella is not initially suspected. The observed associations of host inflammatory responses and microbial sequencing signals with mortality may help identify patients at higher risk of poor outcomes, although their clinical utility requires further validation.

Zitieren

APA

Xu, C., Zhang, L., Chen, S., Liu, T., Zhu, G., Pan, L., Wei, H., An, G., Shi, J., Song, Y., Yang, W., Jiang, E., Yi, H., & Feng, S. (2026). Clinical characteristics and outcomes of PCR-confirmed legionnaires’ disease identified by metagenomic sequencing in patients with hematological diseases. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1826231

Vancouver

Xu C, Zhang L, Chen S, Liu T, Zhu G, Pan L, et al. Clinical characteristics and outcomes of PCR-confirmed legionnaires’ disease identified by metagenomic sequencing in patients with hematological diseases. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1826231

BibTeX
@article{Xu2026,
  author = {Xu, Chunhui and Zhang, Lining and Chen, Shulian and Liu, Teng and Zhu, Guoqing and Pan, Ling and Wei, Hui and An, Gang and Shi, Jun and Song, Yijun and Yang, Wenyu and Jiang, Erlie and Yi, Huiming and Feng, Sizhou},
  title = {Clinical characteristics and outcomes of PCR-confirmed legionnaires’ disease identified by metagenomic sequencing in patients with hematological diseases},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fcimb.2026.1826231}
}
Kostenlos starten →